Steven Vold, MD turns to two in-office solutions from Lumenis to reduce his patients’ dependence on drops and give them back control of their daily life.
6 Tips for Implementing Optima IPL in Your OD Practice
Make dry eye treatment a central focus of your OD practice with these tips for success from Jaime L. King, OD.
Telemedicine for Triage: Life-saving Now and Efficient in the Future
Adapting to the new normal during the pandemic, Douglas K. Devries, OD used telemedicine to his advantage to triage his dry eye patients, avoiding gaps in essential care.
COVID-19 Pandemic: Tips for Staying Connected with Dry Eye Patients
When COVID-19 forced a global shutdown, Bridgitte Shen Lee, OD planned ahead and developed creative ways to continue to serve her dry eye patients remotely.
SLT – Mechanism of Action
Brian Francis, MD – from the University of Southern California of Los Angeles and the Doheny Eye Institute was one of the early adopters of the Selective Laser Trabeculoplasty (SLT) technology – a micro-incisional glaucoma surgical procedure.
Optima IPL Receives CFDA Mark Approval for Treatment of Dry Eye Disease
Optima IPL Receives CFDA Mark Approval for Treatment of Dry Eye Disease
Now this exciting technology is available to practitioners in China for DED
Controversies – Selective Laser Trabeculoplasty vs. Filtration Surgery
Controversies: Selective Laser Trabeculoplasty vs. Filtration Surgery
Duration: 62 mins
Improving Glaucoma Patient Compliance with Selective Laser Trabeculoplasty (SLT)
The value of SLT in a private practice setting, SLT as primary or adjunctive therapy, Reducing or replacing glaucoma medications, The benefits of combining SLT with mono-therapy, Detecting non-adherence with glaucoma therapy, Helping patients cope with the high cost of medications
Duration: 54 mins
Dell et al. (2017): Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction
In a prospective single arm study, Lumenis IPL with OPT™ combined with MGX reduced the number and severity of symptoms and signs of dry eye disease in subjects with moderate to severe MGD.